FDMT vs XPEV · rev $6.8M vs rev $895.7M
4D Molecular Therapeutics Inc (FDMT) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US.
Latest reported FDMT revenue for 2026-06-30 was $6.8M. Net income was -$141.7M. FDMT currently screens at market cap $518.1M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
FDMT currently screens at market cap $518.1M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the FDMT and XPEV stock pages for the full models.
Not investment advice.